Variant report
Variant | nsv606246 |
---|---|
Chromosome Location | chr7:13026143-13028504 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:13015931..13018099-chr7:13026528..13028162,2 | K562 | blood: | |
2 | chr7:12997660..13000139-chr7:13023304..13026150,2 | MCF-7 | breast: | |
3 | chr7:13023717..13025887-chr7:13027646..13029322,2 | K562 | blood: | |
4 | chr7:13021586..13023198-chr7:13026408..13028122,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184753959 | chr7:13026149-13026150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148960352 | chr7:13026178-13026179 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550000206 | chr7:13026207-13026208 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532453448 | chr7:13026228-13026229 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552473644 | chr7:13026241-13026242 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75887456 | chr7:13026284-13026285 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs17166563 | chr7:13026313-13026314 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs143744353 | chr7:13026416-13026417 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11764702 | chr7:13026426-13026427 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs553533449 | chr7:13026484-13026485 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534681526 | chr7:13026503-13026504 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs73678939 | chr7:13026538-13026539 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs538960410 | chr7:13026563-13026564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558855989 | chr7:13026590-13026591 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577827617 | chr7:13026608-13026609 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575507297 | chr7:13026652-13026653 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189447684 | chr7:13026654-13026655 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560715552 | chr7:13026668-13026669 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs75313331 | chr7:13026712-13026713 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs4721172 | chr7:13026715-13026716 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs181821999 | chr7:13026741-13026742 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187167844 | chr7:13026756-13026757 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577912417 | chr7:13026766-13026767 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141073628 | chr7:13026871-13026872 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552386829 | chr7:13026927-13026928 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191551828 | chr7:13026994-13026995 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531505211 | chr7:13026997-13026998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs550962461 | chr7:13027007-13027008 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs139395235 | chr7:13027014-13027015 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530232565 | chr7:13027022-13027023 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546653953 | chr7:13027035-13027036 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368634367 | chr7:13027036-13027037 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs538872374 | chr7:13027045-13027046 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558719931 | chr7:13027057-13027058 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181409749 | chr7:13027110-13027111 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538119064 | chr7:13027153-13027154 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145798063 | chr7:13027182-13027183 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs574326399 | chr7:13027208-13027209 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs77367631 | chr7:13027211-13027212 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553944510 | chr7:13027230-13027231 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs4721173 | chr7:13027260-13027261 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs11761318 | chr7:13027276-13027277 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs34149370 | chr7:13027283-13027284 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs186170753 | chr7:13027351-13027352 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561631951 | chr7:13027354-13027355 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562632275 | chr7:13027365-13027366 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189939657 | chr7:13027374-13027375 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs541729744 | chr7:13027420-13027421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561800069 | chr7:13027459-13027460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182147153 | chr7:13027485-13027486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:13020000-13027000 | Weak transcription | A549 | lung |
2 | chr7:13024400-13027400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr7:13024800-13026400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr7:13024800-13027200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr7:13024800-13027200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr7:13025000-13027000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr7:13025200-13026200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
8 | chr7:13025200-13026400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr7:13025200-13027800 | Weak transcription | Pancreas | Pancrea |
10 | chr7:13025200-13029000 | Weak transcription | Liver | Liver |
11 | chr7:13026000-13026400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr7:13026200-13027400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr7:13026400-13027200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr7:13026600-13026800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr7:13026800-13027000 | Enhancers | H1 Cell Line | embryonic stem cell |
16 | chr7:13026800-13027000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr7:13027000-13027200 | Enhancers | Small Intestine | intestine |
18 | chr7:13027000-13027400 | Enhancers | A549 | lung |
19 | chr7:13027400-13029000 | Weak transcription | A549 | lung |
20 | chr7:13027800-13028200 | Enhancers | Pancreas | Pancrea |